These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 15936010

  • 1. Free/Total PSA (F/T ratio) kinetics in patients with clinically localized prostate cancer undergoing radical prostatectomy.
    Gregorakis AK, Malovrouvas D, Stefanakis S, Petraki K, Scorilas A.
    Clin Chim Acta; 2005 Jul 24; 357(2):196-201. PubMed ID: 15936010
    [Abstract] [Full Text] [Related]

  • 2. Total and free PSA kinetics in patients without prostate cancer undergoing radical cystoprostatectomy.
    Gregorakis AK, Stefanakis S, Malovrouvas D, Petraki K, Gourgiotis D, Scorilas A.
    Prostate; 2008 May 15; 68(7):759-65. PubMed ID: 18213630
    [Abstract] [Full Text] [Related]

  • 3. Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues.
    Björk T, Schalken J, Wittjes W, Ljungberg B, Lilja H.
    Prostate; 2001 Apr 15; 47(1):14-20. PubMed ID: 11304725
    [Abstract] [Full Text] [Related]

  • 4. Clearance rate of serum-free and total PSA following radical retropubic prostatectomy.
    Partin AW, Piantadosi S, Subong EN, Kelly CA, Hortopan S, Chan DW, Wolfert RL, Rittenhouse HG, Carter HB.
    Prostate Suppl; 1996 Apr 15; 7():35-9. PubMed ID: 8950362
    [Abstract] [Full Text] [Related]

  • 5. [Is radical prostatectomy a suitable model for determination of PSA half-life?].
    Brändle E, Gottfried HW, Maier S, Flohr P, Steinbach G, Hautmann RE.
    Urologe A; 1995 Sep 15; 34(5):419-23. PubMed ID: 7483161
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy.
    Bastian PJ, Palapattu GS, Yegnasubramanian S, Lin X, Rogers CG, Mangold LA, Trock B, Eisenberger M, Partin AW, Nelson WG.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 1):5361-7. PubMed ID: 17875764
    [Abstract] [Full Text] [Related]

  • 7. Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10 ng/ml.
    Shariat SF, Abdel-Aziz KF, Roehrborn CG, Lotan Y.
    Eur Urol; 2006 Feb 15; 49(2):293-302. PubMed ID: 16387412
    [Abstract] [Full Text] [Related]

  • 8. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
    Haukaas SA, Halvorsen OJ, Daehlin L, Hostmark J, Akslen LA.
    BJU Int; 2006 Jan 15; 97(1):51-5. PubMed ID: 16336328
    [Abstract] [Full Text] [Related]

  • 9. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
    Capitanio U, Scattoni V, Freschi M, Briganti A, Salonia A, Gallina A, Colombo R, Karakiewicz PI, Rigatti P, Montorsi F.
    Eur Urol; 2008 Jul 15; 54(1):118-25. PubMed ID: 18314255
    [Abstract] [Full Text] [Related]

  • 10. Prostate specific antigen nadir determined using ultra-sensitive prostate specific antigen as a predictor of biochemical progression after radical prostatectomy in Japanese males.
    Kinoshita H, Kamoto T, Nishiyama H, Nakamura E, Matsuda T, Ogawa O.
    Int J Urol; 2007 Oct 15; 14(10):930-4; discussion 934. PubMed ID: 17880291
    [Abstract] [Full Text] [Related]

  • 11. Kinetics of serum total and free prostate-specific antigen (PSA) after extended multisite prostate biopsy: Comparison among biopsy, transurethral resection of the prostate (TURP), and biopsy plus TURP.
    Hara N, Koike H, Nobushita T, Miyajima N, Kawaguchi M, Nishiyama T, Takahashi K, Hohenfellner R.
    Urol Oncol; 2010 Oct 15; 28(4):355-9. PubMed ID: 19110451
    [Abstract] [Full Text] [Related]

  • 12. Outcome after radical prostatectomy in young men with or without a family history of prostate cancer.
    Rouprêt M, Fromont G, Bitker MO, Gattegno B, Vallancien G, Cussenot O.
    Urology; 2006 May 15; 67(5):1028-32. PubMed ID: 16698363
    [Abstract] [Full Text] [Related]

  • 13. Is pelvic lymph node dissection necessary in patients with a serum PSA<10ng/ml undergoing radical prostatectomy for prostate cancer?
    Schumacher MC, Burkhard FC, Thalmann GN, Fleischmann A, Studer UE.
    Eur Urol; 2006 Aug 15; 50(2):272-9. PubMed ID: 16632187
    [Abstract] [Full Text] [Related]

  • 14. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer.
    Nelson BA, Shappell SB, Chang SS, Wells N, Farnham SB, Smith JA, Cookson MS.
    BJU Int; 2006 Jun 15; 97(6):1169-72. PubMed ID: 16686706
    [Abstract] [Full Text] [Related]

  • 15. Radical prostatectomy for clinical stage T3a disease.
    Freedland SJ, Partin AW, Humphreys EB, Mangold LA, Walsh PC.
    Cancer; 2007 Apr 01; 109(7):1273-8. PubMed ID: 17315165
    [Abstract] [Full Text] [Related]

  • 16. Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy.
    Lilja H, Haese A, Björk T, Friedrich MG, Piironen T, Pettersson K, Huland E, Huland H.
    J Urol; 1999 Dec 01; 162(6):2029-34; discussion 2034-5. PubMed ID: 10569562
    [Abstract] [Full Text] [Related]

  • 17. More favorable tumor features and progression-free survival rates in a longitudinal prostate cancer screening study: PSA era and threshold-specific effects.
    Jang TL, Han M, Roehl KA, Hawkins SA, Catalona WJ.
    Urology; 2006 Feb 01; 67(2):343-8. PubMed ID: 16442594
    [Abstract] [Full Text] [Related]

  • 18. Radical prostatectomy for high-risk prostate cancer: biochemical outcome.
    Kawamorita N, Saito S, Ishidoya S, Ito A, Saito H, Kato M, Arai Y.
    Int J Urol; 2009 Sep 01; 16(9):733-8. PubMed ID: 19674167
    [Abstract] [Full Text] [Related]

  • 19. Serum tPSA, cPSA, related density parameters and chromogranin A as predictors of positive margins after radical prostatectomy.
    Custovic Z, Kraus O, Tomaskovic I, Tarle M.
    Anticancer Res; 2007 Sep 01; 27(4C):2817-21. PubMed ID: 17695453
    [Abstract] [Full Text] [Related]

  • 20. Recurrent PSA after prostatectomy for prostate cancer: implications of PSA doubling time.
    Ashley T.
    J Insur Med; 2003 Sep 01; 35(3-4):161-4. PubMed ID: 14971088
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.